23. Symposium of the AGNP

Abstracts (HTML) Autorenliste

Padberg, F.

EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline
Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM
Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity
Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)

Panhuysen, M.

Inbred mouse strains as models for the detection of genes relevant for the effects of antidepressants

Parsons, C.

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor

Pechler, S.

Neural representation of cognitive changes within the visual system in the AD brain

Pedrosa Gil, F.

Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression

Penzel, T.

Actigraphy in patients with depression and schizophrenia concerning activity levels, sleep estimation and circadian rhythm

Perfahl, M.

Ultrasonic gait analysis: Differentiation of effects of schizophrenia and of antipsychotic treatment
Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses

Peters, M.

Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B

Petersen, I.

Effect of antipsychotics on microglia in vitro

Pfeiff, L.

Ultrasonic gait analysis: Differentiation of effects of schizophrenia and of antipsychotic treatment
Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses

Pfennig, A.

HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?
Munich Vulnerability Study – Familial vulnerability for affective disorders: Search for endophenotypes
Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders
Prediction of response to antidepressant monotherapy
Is there a genetic continuum between anxiety and depression?

Pfister, H.

High cholesterol, triglycerides, and body-mass index in suicide attempters with major depression

Philipsen, X.

Clonidine in the treatment of acute states of aversive tension and dissociation in female patients with borderline personality disorder

Pich, M.

Interferon-alpha treatment and serotonergic dysfunction

Pitschel-Walz, G.

Peer-to-peer education in schizophrenia: Impact for knowledge, compliance with neuroleptic relapse prevention and quality of life
Results of a pilot study about the effects of a new, video based psychoeducational program for neuroleptic relapse prevention

Plewnia, C.

Treatment of tics in Tourette’s syndrome with aripiprazole

Plodeck, V.

CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates

Pogarell, O.

EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline
Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease
Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants
Effects of citalopram and reboxetine on the loudness dependence of auditory evoked potentials in patients with major depression
Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM
Loudness dependency of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI
Prediction of treatment response in major depression: The relationship between the serotonin-related LDAEP and the unspecific prediction related to anterior cingulate cortex activity
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*

Pohlmann, K.

Cortisol-reducing properties of quetiapine in healthy subjects under an undisturbed and an acoustic stress condition
Quetiapine improves sleep quality in healthy subjects

Pollmächer, T.

Immune-neuroendocrine interactions and their influence on the immune function in patients with depressive disorders
Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects – First results from a double-blind, placebocontrolled study
Influence of sleep deprivation on plasma ghrelin levels in healthy subjects
Different brain reactivity during phasic and tonic REM sleep: A simultaneous FMRI and EEG study
Processing of acoustic stimuli during NREM sleep: Results from a simultaneous fMRI and EEG study
Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain
Early prediction of changes in weight during six weeks of treatment with antidepressants
Body weight and the plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium
Epidemiology and mechanisms of weight gain induced by psychotropic drugs
Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects
Thalamo-cortical synchronization across the sleep-wake cycle: A combined fMRI/EEG study

Ponath, G.

Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B

Pöpperl, G.

Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM

Poser, W.

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Poustka, F.

The specificity of weak central coherence: The neuropsychological profile of autistic patients in contrast to depressive patients, schizophrenic patients and control subjects

Pragst, F.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers

Preuss, U. W.

Possible changes of hippocampus and amygdala in borderline personality disorder: A structural magnetic resonance imaging study

Pridzun, L.

Leptin levels of alcohol abstainers and detoxification patients are not different

Priebe, M.

Alcohol-craving: Therapeutic effects using fMRI

Propp, S.

Loudness dependency of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI

Pruessner, J. C.

Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline

Pugner, K.

Psychotropic polypharmacy. An analysis of a large outpatient prescription database

Putzhammer, A.

The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression
Ultrasonic gait analysis: Differentiation of effects of schizophrenia and of antipsychotic treatment
Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses